- Home
- HBB vs NAUT Comparison
HBB vs NAUT Comparison
Compare HBB & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBB
- NAUT
- Stock Information
- Founded
- HBB 1904
- NAUT 2016
- Country
- HBB United States
- NAUT United States
- Employees
- HBB N/A
- NAUT N/A
- Industry
- HBB Home Furnishings
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- HBB Consumer Discretionary
- NAUT Industrials
- Exchange
- HBB Nasdaq
- NAUT Nasdaq
- Market Cap
- HBB 196.2M
- NAUT 104.7M
- IPO Year
- HBB 2017
- NAUT N/A
- Fundamental
- Price
- HBB $14.96
- NAUT $1.27
- Analyst Decision
- HBB
- NAUT Strong Sell
- Analyst Count
- HBB 0
- NAUT 1
- Target Price
- HBB N/A
- NAUT $1.75
- AVG Volume (30 Days)
- HBB 23.5K
- NAUT 533.0K
- Earning Date
- HBB 10-29-2025
- NAUT 10-28-2025
- Dividend Yield
- HBB 3.23%
- NAUT N/A
- EPS Growth
- HBB N/A
- NAUT N/A
- EPS
- HBB 2.35
- NAUT N/A
- Revenue
- HBB $631,318,000.00
- NAUT N/A
- Revenue This Year
- HBB N/A
- NAUT N/A
- Revenue Next Year
- HBB N/A
- NAUT N/A
- P/E Ratio
- HBB $6.47
- NAUT N/A
- Revenue Growth
- HBB N/A
- NAUT N/A
- 52 Week Low
- HBB $12.72
- NAUT $0.62
- 52 Week High
- HBB $31.72
- NAUT $2.92
- Technical
- Relative Strength Index (RSI)
- HBB 52.39
- NAUT 66.52
- Support Level
- HBB $15.09
- NAUT $0.95
- Resistance Level
- HBB $15.94
- NAUT $1.57
- Average True Range (ATR)
- HBB 0.58
- NAUT 0.13
- MACD
- HBB 0.09
- NAUT 0.04
- Stochastic Oscillator
- HBB 54.21
- NAUT 59.64
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.